Ali Akbar Fazaeli (Aliakbar Fazaeli)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 9

Top Topics

Metastatic Breast Cancer

Convolutional Neural Network

Top Venues

BMC public health

BMC health services research

Cost effectiveness and resource allocation : C/E

Health economics review

This page only lists publications with an associated author ORCID identifier.

Publications

Maryam Hedayati, Mohammadreza Maleki, Iravan Masoudi Asl, Ali Akbar Fazaeli, Salime Goharinezhad
Exploring the driving forces and scenario analysis for catastrophic and impoverishing health expenditures in Iran. BMC health services research 24 (1) (2024)
Mahya Razimoghadam, Mehdi Yaseri, Mehdi Rezaee, Ali Akbar Fazaeli, Rajabali Darroudi
Non-COVID-19 hospitalization and mortality during the COVID-19 pandemic in Iran: a longitudinal assessment of 41 million people in 2019-2022. BMC public health 24 (1) (2024)
Mahya Razimoghadam, Mehdi Yaseri, Mehdi Rezaee, Ali Akbar Fazaeli, Rajabali Darroudi
Non-COVID-19 hospitalization and mortality during the COVID-19 pandemic in Iran: a longitudinal assessment of 41 million people in 2019-2022. BMC public health 24 (1) (2024)
Mahya Razimoghadam, Mehdi Yaseri, Mehdi Rezaee, Ali Akbar Fazaeli, Rajabali Darroudi
Non-COVID-19 hospitalization and mortality during the COVID-19 pandemic in Iran: a longitudinal assessment of 41 million people in 2019-2022. BMC public health 24 (1) (2024)
Maryam Hedayati, Mohammadreza Maleki, Iravan Masoudi Asl, Ali Akbar Fazaeli, Salime Goharinezhad
Exploring the driving forces and scenario analysis for catastrophic and impoverishing health expenditures in Iran. BMC health services research 24 (1) (2024)
Maryam Hedayati, Mohammadreza Maleki, Iravan Masoudi Asl, Ali Akbar Fazaeli, Salime Goharinezhad
Exploring the driving forces and scenario analysis for catastrophic and impoverishing health expenditures in Iran. BMC health services research 24 (1) (2024)
Mahya Razimoghadam, Mehdi Yaseri, Mehdi Rezaee, Ali Akbar Fazaeli, Rajabali Darroudi
Non-COVID-19 hospitalization and mortality during the COVID-19 pandemic in Iran: a longitudinal assessment of 41 million people in 2019-2022. BMC public health 24 (1) (2024)
Ali Darvishi, Rajabali Daroudi, Ali Akbar Fazaeli
Cost-utility analysis of Palbociclib + letrozole and ribociclib + letrozole versus Letrozole monotherapy in the first-line treatment of metastatic breast cancer in Iran using partitioned survival model. Health economics review 13 (1) (2023)
Mohamad Yousefi Nayer, Ali Akbar Fazaeli, Yadollah Hamidi
Hospital efficiency measurement in the west of Iran: data envelopment analysis and econometric approach. Cost effectiveness and resource allocation : C/E 20 (1) (2022)